National Cancer Institute Notice of Closed Meeting, 55558 [2018-24223]

Download as PDF 55558 Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group, Heart, Lung, and Blood Program Project Review Committee. Date: November 30, 2018. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton BWI (Baltimore), 1100 Old Elkridge Landing Road, Baltimore, MD 21090. Contact Person: Jeffrey H. Hurst, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892, 301–435–0303, hurstj@ nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 31, 2018. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Lasker Clinical Scholars Review. Date: November 14, 2018. Time: 11:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Caron A. Lyman, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 31, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–24223 Filed 11–5–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2018–24221 Filed 11–5–18; 8:45 am] BILLING CODE 4140–01–P Transportation Security Administration DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Approved ThirdParty Canine-Cargo Certifiers, and Start of Certification Events Transportation Security Administration, DHS. ACTION: Notice. AGENCY: khammond on DSK30JT082PROD with NOTICES National Institutes of Health National Cancer Institute Notice of Closed Meeting VerDate Sep<11>2014 17:05 Nov 05, 2018 Jkt 247001 The Transportation Security Administration (TSA) has approved the following organizations to assess thirdparty explosives detection canine teams to determine whether they meet TSA’s standards for screening air cargo. This notice announces the list of approved SUMMARY: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 certifying organizations, and establishes a certification start date of November 1, 2018. TSA-approved 3PK9–C Certifiers may begin certifying canine teams to TSA standards effective November 1, 2018, and may continue to certify teams thereafter. All certification events must be conducted in accordance with the requirements of the 3PK9–C Order, by an Authorized Evaluator employed by a TSA-approved 3PK9–C Certifier. DATES: The certification start date is effective November 1, 2018. ADDRESSES: Interested parties can contact 3PKCert@tsa.dhs.gov to obtain information about the certification program. FOR FURTHER INFORMATION CONTACT: Christopher Shelton, 3PK9–C Team, Canine Training Center, Training and Development, Transportation Security Administration, U.S. Department of Homeland Security; email to 3PKCert@ tsa.dhs.gov; telephone at (210) 396–4425 (desk); fax to (210) 671–4911. SUPPLEMENTARY INFORMATION: Background TSA created the Third-Party CanineCargo (3PK9–C) Program, under TSA’s regulations for Certified Cargo Screening Programs (CCSP), see 49 CFR part 1549, to provide an efficient and effective method for screening air cargo to TSA’s standards. Under this program, thirdparty canine teams trained in explosives detection can be certified by a nongovernmental entity, acting under the approval of TSA, as meeting TSA’s certification standards. Certified 3PK9– C teams can be deployed to screen air cargo for aircraft operators, foreign air carriers, and other TSA-regulated parties operating under a TSA-approved or accepted security program. On May 18, 2018, TSA published a notice in the Federal Register seeking applications from qualified persons interested in becoming an approved 3PK9–C Certifier under the 3PK9–C Program. See 83 FR 23287. The CCSP–K9 security program will define the requirements that TSAregulated canine explosives detection teams must meet when screening cargo for air carriers and screening facilities and will include eligibility requirements for canine explosives detection teams. These eligibility requirements for canine explosives detection teams include, but are not limited to, experience, education, vetting, and citizenship requirements for canine team handlers. These eligibility requirements for canine explosives detection teams are not contained in the 3PK9 Certifier Order. The 3PK9 Security Program and Order E:\FR\FM\06NON1.SGM 06NON1

Agencies

[Federal Register Volume 83, Number 215 (Tuesday, November 6, 2018)]
[Notices]
[Page 55558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24223]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Lasker Clinical Scholars Review.
    Date: November 14, 2018.
    Time: 11:30 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Caron A. Lyman, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 31, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24223 Filed 11-5-18; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.